Variant report
Variant | nsv3902 |
---|---|
Chromosome Location | chr3:86808374-86821132 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CHMP2B-4 | chr3:86811955-86812025 | l_2406_chr3:86790895-86851827_testes |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548911570 | chr3:86809805-86809806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563704832 | chr3:86809811-86809812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530796620 | chr3:86809863-86809864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550172925 | chr3:86809892-86809893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563594752 | chr3:86809945-86809946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190618743 | chr3:86809969-86809970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143867259 | chr3:86810025-86810026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529090710 | chr3:86810032-86810033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559052067 | chr3:86810063-86810064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547153443 | chr3:86810064-86810065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532659636 | chr3:86810074-86810075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146854668 | chr3:86810097-86810098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551045617 | chr3:86810121-86810122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115099105 | chr3:86810136-86810137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs13083977 | chr3:86810152-86810153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182289620 | chr3:86810186-86810187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556025896 | chr3:86810194-86810195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185478761 | chr3:86812001-86812002 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs73844285 | chr3:86813843-86813844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558693867 | chr3:86813844-86813845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150561600 | chr3:86813921-86813922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183588303 | chr3:86813926-86813927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187706717 | chr3:86813950-86813951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556151015 | chr3:86813975-86813976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574336978 | chr3:86813995-86813996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12492726 | chr3:86813997-86813998 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs560410654 | chr3:86814014-86814015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527884177 | chr3:86814034-86814035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545950908 | chr3:86814038-86814039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139309919 | chr3:86814046-86814047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs193229553 | chr3:86814116-86814117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549987285 | chr3:86814234-86814235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561740540 | chr3:86814292-86814293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529300399 | chr3:86814295-86814296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548504135 | chr3:86814301-86814302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs149578646 | chr3:86814307-86814308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs533992810 | chr3:86814337-86814338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569353577 | chr3:86814412-86814413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558756971 | chr3:86814419-86814420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12493521 | chr3:86814420-86814421 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs72910443 | chr3:86814476-86814477 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs555977936 | chr3:86814484-86814485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574421813 | chr3:86814522-86814523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541378017 | chr3:86814536-86814537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554053408 | chr3:86814537-86814538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144243283 | chr3:86814600-86814601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs72910450 | chr3:86818194-86818195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547301148 | chr3:86818210-86818211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571789683 | chr3:86818224-86818225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539222910 | chr3:86818230-86818231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:86809800-86810200 | Enhancers | Hela-S3 | cervix |
2 | chr3:86813800-86814600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:86814400-86814600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr3:86818000-86818400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr3:86820800-86821200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr3:86820800-86821400 | Active TSS | Spleen | Spleen |
7 | chr3:86821000-86821200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr3:86821000-86822200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |